A clinical approach to hypertrophic pachymeningitis.
Abrantes FF, Moraes MPM, Rezende Filho FM, Pedroso JL, Barsottini OGP.
Arq Neuropsiquiatr. 2020 Dec;78(12):797-804. doi: 10.1590/0004-282X20200073.
IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment.
Lu LX, Della-Torre E, Stone JH, Clark SW.
JAMA Neurol. 2014 Jun;71(6):785-93. doi: 10.1001/jamaneurol.2014.243.
Immune-Mediated Hypertrophic Pachymeningitis and its Mimickers: Magnetic Resonance Imaging Findings.
Matias TB, Cordeiro RA, Duarte JA, de Jarry VM, Appenzeller S, Villarinho L, Reis F.
Acad Radiol. 2023 Nov;30(11):2696-2706. doi: 10.1016/j.acra.2023.01.017. Epub 2023 Mar 6.
Hypertrophic pachymeningitis.
Hahn LD, Fulbright R, Baehring JM.
J Neurol Sci. 2016 Aug 15;367:278-83. doi: 10.1016/j.jns.2016.06.024. Epub 2016 Jun 11.
Hypertrophic pachymeningitis in polyarteritis nodosa: a case-based review.
Nomura S, Shimojima Y, Kondo Y, Kishida D, Sekijima Y.
Clin Rheumatol. 2022 Feb;41(2):567-572. doi: 10.1007/s10067-021-05971-6. Epub 2021 Nov 2.
Hypertrophic pachymeningitis.
Dziedzic T, Wojciechowski J, Nowak A, Marchel A.
Childs Nerv Syst. 2015 Jul;31(7):1025-31. doi: 10.1007/s00381-015-2680-z. Epub 2015 Mar 15.
Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease.
De Virgilio A, de Vincentiis M, Inghilleri M, Fabrini G, Conte M, Gallo A, Rizzo MI, Greco A.
Immunol Res. 2017 Feb;65(1):386-394. doi: 10.1007/s12026-016-8863-1.
Idiopathic hypertrophic pachymeningitis.
Kupersmith MJ, Martin V, Heller G, Shah A, Mitnick HJ.
Neurology. 2004 Mar 9;62(5):686-94. doi: 10.1212/01.wnl.0000113748.53023.b7.
Is Hypertrophic Pachymeningitis Really Idiopathic?
Jagiasi K, Barvalia PP.
Neurol India. 2022 Nov-Dec;70(6):2422-2426. doi: 10.4103/0028-3886.364052.
MOG-antibody-associated hypertrophic pachymeningitis.
Papathanasiou A, Yeo JM, Humberstone M, Hosseini AA.
Mult Scler Relat Disord. 2020 Jul;42:102074. doi: 10.1016/j.msard.2020.102074. Epub 2020 Apr 26.
